DataMEDS AI signs supply deal to compound six peptides including BPC-157 and TB-500
Its Corexa subsidiary plans to start dispensing compounded peptide prescriptions in November 2026, citing the new HHS policy. The peptides remain unapproved.
Recap by typeshit. Full story at USA TODAY.